These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 18295155
1. Psychopharmacological interventions. Biederman J, Spencer TJ. Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):439-58, xi. PubMed ID: 18295155 [Abstract] [Full Text] [Related]
2. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. J Am Acad Child Adolesc Psychiatry; 1996 Apr; 35(4):409-32. PubMed ID: 8919704 [Abstract] [Full Text] [Related]
3. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [Abstract] [Full Text] [Related]
4. Pharmacotherapy of attention deficit hyperactivity disorder. Spencer T, Biederman J, Wilens T. Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191 [Abstract] [Full Text] [Related]
5. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL. Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [Abstract] [Full Text] [Related]
11. Multimodal treatment for childhood attention-deficit/hyperactivity disorder. Kaiser NM, Hoza B, Hurt EA. Expert Rev Neurother; 2008 Oct 15; 8(10):1573-83. PubMed ID: 18928349 [Abstract] [Full Text] [Related]
12. Annotation: Principles of treatment for hyperkinetic disorder: practice approaches for the U.K. Overmeyer S, Taylor E. J Child Psychol Psychiatry; 1999 Nov 15; 40(8):1147-57. PubMed ID: 10604394 [No Abstract] [Full Text] [Related]
13. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT. Ann Pharmacother; 2009 Jun 15; 43(6):1084-95. PubMed ID: 19470858 [Abstract] [Full Text] [Related]
14. Stimulant medications. Greenhill LL, Halperin JM, Abikoff H. J Am Acad Child Adolesc Psychiatry; 1999 May 15; 38(5):503-12. PubMed ID: 10230181 [Abstract] [Full Text] [Related]
15. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. Rader R, McCauley L, Callen EC. Am Fam Physician; 2009 Apr 15; 79(8):657-65. PubMed ID: 19405409 [Abstract] [Full Text] [Related]
16. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children. August GJ, Realmuto GM. Minn Med; 2000 Jun 15; 83(6):45-6. PubMed ID: 10881573 [No Abstract] [Full Text] [Related]
17. Psychosocial interventions in attention deficit hyperactivity disorder. Antshel KM, Barkley R. Child Adolesc Psychiatr Clin N Am; 2008 Apr 15; 17(2):421-37, x. PubMed ID: 18295154 [Abstract] [Full Text] [Related]
18. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments. Stein MA. Am J Manag Care; 2004 Jul 15; 10(4 Suppl):S89-98. PubMed ID: 15352535 [Abstract] [Full Text] [Related]